Live Breaking News & Updates on Drug administration okd qelbree kell bree

Stay informed with the latest breaking news from Drug administration okd qelbree kell bree on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Drug administration okd qelbree kell bree and stay connected to the pulse of your community

FDA OKs first new ADHD drug in over a decade for children

This undated image provided by Supernus Pharmaceuticals in April 2021 shows bottles for different dosages of the drug Qelbree. On Friday, April 2, 2021, the U.S. Food and Drug Administration approved the medication for treating attention deficit hyperactivity disorder in children ages six through 17. (Supernus Pharmaceuticals via AP)
health
FDA OKs first new ADHD drug in over a decade for children
Today
05:47 am JST
Today | 06:48 am JST
WASHINGTON
U.S. regulators have approved the first new drug in over a decade for children with ADHD, which causes inattention, hyperactivity and impulsivity.
The Food and Drug Administration OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily.

Maryland , United-states , Baltimore , American , Davidw-goodman , Drug-administration-okd-qelbree-kell-bree , Johns-hopkins-school-of-medicine , Psychiatric-associates , Supernus-pharmaceuticals-of-rockville , Drug-administration , Supernus-pharmaceuticals